GTC
FLXN

Ghost Tree Capital’s Flexion Therapeutics, Inc. FLXN Stock Holding History

Ghost Tree Capital’s Portfolio FLXN Stock Details FLXN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q4 		– Sell
-12,488
Closed -$228K – 88
2014
Q3 		$228K Buy
+12,488
New +$181K 0.12% 69
2014
Q2 		– Sell
-40,000
Closed -$658K – 82
2014
Q1 		$658K Buy
+40,000
New +$691K 0.39% 55

Other funds holding FLXN

NHAS
Novo Holdings A/S Hellerup, Denmark $1.72B AUM 106.92% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
GGHC
Gilder Gagnon Howe & Co New York $9.69B AUM 55.7% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
KCM
Kingdon Capital Management New York $976M AUM 66.76% 1-Year Est. Return
BC
Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return
VAM
Visium Asset Management New York $1.43B AUM 3.58% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return
Schroder Investment Management Group
Schroder Investment Management Group London, United Kingdom $141B AUM 34.18% 1-Year Est. Return

Ghost Tree Capital's FLXN Position: Q4 2014 in Review

Ghost Tree Capital sold out of Flexion Therapeutics, Inc. (FLXN) in Q4 2014, closing a stake of 12,488 shares — an estimated $228K sold.

Ghost Tree Capital first reported a position in FLXN in Q1 2014 and held it in 2 quarters. The position peaked at $658K in Q1 2014. 44 funds tracked by Wall St. Rank hold FLXN as of Q4 2014.

  • Ghost Tree Capital reported no remaining Flexion Therapeutics, Inc. position as of Q4 2014 after selling out during the quarter.
  • Ghost Tree Capital sold 12,488 Flexion Therapeutics, Inc. shares in Q4 2014, an estimated $228K.
  • Ghost Tree Capital first reported a position in Flexion Therapeutics, Inc. in Q1 2014 and held it in 2 quarters.
  • Ghost Tree Capital's Flexion Therapeutics, Inc. position peaked at $658K in Q1 2014.
  • 44 funds tracked by Wall St. Rank held Flexion Therapeutics, Inc. as of Q4 2014.

Based on Ghost Tree Capital's 13F filing for Q4 2014, filed 17 Feb 2015.